Download PDF
Semin Respir Crit Care Med 2009; 30(4): 493-501
DOI: 10.1055/s-0029-1233318
© Thieme Medical Publishers

Atrial Septostomy and Transplantation for Patients with Pulmonary Arterial Hypertension

Paul A. Corris1
  • 1Institute of Cellular Medicine, Newcastle University and Freeman Hospital, United Kingdom
Further Information

Publication History

Publication Date:
24 July 2009 (online)

    Permissions and Reprints

ABSTRACT

The development of specific disease-targeted therapy for pulmonary arterial hypertension has offered a major advancement in the management of patients, and these medical treatments have been shown to improve both quality and quantity of life. Nevertheless, many patients deteriorate with time and will require consideration of other approaches. This article focuses on the roles of atrial septostomy and lung transplantation.

KEYWORDS

Pulmonary arterial hypertension - atrial septostomy - right ventricular failure - lung transplantation - selection criteria - outcomes

REFERENCES

  • 1 D'Alonzo G E, Barst R J, Ayres S M et al.. Survival in patients with primary pulmonary hypertension: results from a national prospective registry.  Ann Intern Med. 1991;  115 343-349
    PubMedGoogle Scholar
  • 2 Nihill M R, O'Laughlin M P, Mullins C E. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease.  Cathet Cardiovasc Diagn. 1991;  24 166-172
    CrossrefPubMedGoogle Scholar
  • 3 Kerstein D, Levy P S, Hsu D T, Hordof A J, Gersony W M, Barst R J. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension.  Circulation. 1995;  91 2028-2035
    PubMedGoogle Scholar
  • 4 Austen W G, Morrow A G, Berry W B. Experimental studies of the surgical treatment of primary pulmonary hypertension.  J Thorac Cardiovasc Surg. 1964;  48 448-455
    PubMedGoogle Scholar
  • 5 Hopkins W E. The remarkable right ventricle of patients with Eisenmenger syndrome.  Coron Artery Dis. 2005;  16 19-25
    CrossrefPubMedGoogle Scholar
  • 6 Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension.  Am J Cardiol. 1983;  51 1560-1561
    CrossrefPubMedGoogle Scholar
  • 7 Hausknecht M J, Sims R E, Nihill M R, Cashion W R. Successful palliation of primary pulmonary hypertension by atrial septostomy.  Am J Cardiol. 1990;  65 1045-1046
    CrossrefPubMedGoogle Scholar
  • 8 Bristow M R, Zisman L S, Lowes B D et al.. The pressure-overloaded right ventricle in pulmonary hypertension.  Chest. 1998;  114(1, Suppl) 101S-106S
    CrossrefPubMedGoogle Scholar
  • 9 Micheletti A, Hislop A A, Lammers A et al.. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension.  Heart. 2006;  92 969-972
    CrossrefPubMedGoogle Scholar
  • 10 Rosenzweig E B, Kerstein D, Barst R J. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.  Circulation. 1999;  99 1858-1865
    CrossrefPubMedGoogle Scholar
  • 11 Simonneau G, Barst R J, Galie N Treprostinil Study Group et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.  Am J Respir Crit Care Med. 2002;  165 800-804
    CrossrefPubMedGoogle Scholar
  • 12 Galiè N, Beghetti M, Gatzoulis M A Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.  Circulation. 2006;  114 48-54
    CrossrefPubMedGoogle Scholar
  • 13 Sandoval J, Gaspar J. Atrial septostomy. In: Peacock AJ, Rubin LJ Pulmonary Circulation. 2nd ed. London; Edward Arnold 2004: 319-333
    Google Scholar
  • 14 Rich S, Dodin E, McLaughlin V V. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application.  Am J Cardiol. 1997;  80 369-371
    CrossrefPubMedGoogle Scholar
  • 15 Sandoval J, Rothman A, Pulido T. Atrial septostomy for pulmonary hypertension.  Clin Chest Med. 2001;  22 547-560
    CrossrefPubMedGoogle Scholar
  • 16 Rothman A, Sklansky M S, Lucas V W et al.. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension.  Am J Cardiol. 1999;  84 682-686
    CrossrefPubMedGoogle Scholar
  • 17 Klepetko W, Mayer E, Sandoval J et al.. Interventional and surgical modalities of treatment for pulmonary arterial hypertension.  J Am Coll Cardiol. 2004;  43(12, Suppl S) 73S-80S
    CrossrefPubMedGoogle Scholar
  • 18 Reichenberger F, Pepke-Zaba J, McNeil K, Parameshwar J, Shapiro L M. Atrial septostomy in the treatment of severe pulmonary arterial hypertension.  Thorax. 2003;  58 797-800
    CrossrefPubMedGoogle Scholar
  • 19 Velez-Roa S, Ciarka A, Najem B, Vachiery J L, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension.  Circulation. 2004;  110 1308-1312
    CrossrefPubMedGoogle Scholar
  • 20 Kurzyna M, Dabrowski M, Bielecki D et al.. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension.  Chest. 2007;  131 977-983
    CrossrefPubMedGoogle Scholar
  • 21 Law M A, Grifka R G, Mullins C E, Nihill M R. Atrial septostomy improves survival in select patients with pulmonary hypertension.  Am Heart J. 2007;  153 779-784
    CrossrefPubMedGoogle Scholar
  • 22 Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report—2005.  J Heart Lung Transplant. 2005;  24 956-967
    CrossrefPubMedGoogle Scholar
  • 23 Charman S C, Sharples L D, McNeil K D, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis.  J Heart Lung Transplant. 2002;  21 226-232
    CrossrefPubMedGoogle Scholar
  • 24 De Meester J, Smits J M, Persijn G G, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience.  J Heart Lung Transplant. 2001;  20 518-524
    CrossrefPubMedGoogle Scholar
  • 25 Thabut G, Mal H, Castier Y et al.. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis.  J Thorac Cardiovasc Surg. 2003;  126 469-475
    CrossrefPubMedGoogle Scholar
  • 26 Geertsma A, Ten Vergert E M, Bonsel G J, de Boer W J, van der Bij W. Does lung transplantation prolong life? A comparison of survival with and without transplantation.  J Heart Lung Transplant. 1998;  17 511-516
    PubMedGoogle Scholar
  • 27 Hosenpud J D, Bennett L E, Keck B M, Edwards E B, Novick R J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.  Lancet. 1998;  351 24-27
    CrossrefPubMedGoogle Scholar
  • 28 Gerbase M W, Spiliopoulos A, Rochat T, Archinard M, Nicod L P. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome.  Chest. 2005;  128 1371-1378
    CrossrefPubMedGoogle Scholar
  • 29 Gross C R, Savik K, Bolman III R M, Hertz M I. Long-term health status and quality of life outcomes of lung transplant recipients.  Chest. 1995;  108 1587-1593
    CrossrefPubMedGoogle Scholar
  • 30 Maish A B. Priorities for lung transplantation among patients with cystic fibrosis.  JAMA. 2002;  287 1524-1525 author reply 1524-1525
    PubMedGoogle Scholar
  • 31 Kanasky Jr W F, Anton S D, Rodrigue J R, Perri M G, Szwed T, Baz M A. Impact of body weight on long-term survival after lung transplantation.  Chest. 2002;  121 401-406
    CrossrefPubMedGoogle Scholar
  • 32 Sitbon O, Humbert M, Nunes H et al.. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.  J Am Coll Cardiol. 2002;  40 780-788
    CrossrefPubMedGoogle Scholar
  • 33 McLaughlin V V, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.  Circulation. 2002;  106 1477-1482
    CrossrefPubMedGoogle Scholar
  • 34 Orens J B, Estenne M, Arcasoy S Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation et al. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.  J Heart Lung Transplant. 2006;  25 745-755
    CrossrefPubMedGoogle Scholar
  • 35 Bando K, Keenan R J, Paradis I L et al.. Impact of pulmonary hypertension on outcome after single-lung transplantation.  Ann Thorac Surg. 1994;  58 1336-1342
    CrossrefPubMedGoogle Scholar
  • 36 McCarthy P M, Rosenkranz E R, White R D et al.. Single-lung transplantation with atrial septal defect repair for Eisenmenger's syndrome.  Ann Thorac Surg. 1991;  52 300-303
    PubMedGoogle Scholar
  • 37 Pasque M K, Trulock E P, Kaiser L R, Cooper J D. Single-lung transplantation for pulmonary hypertension: three-month hemodynamic follow-up.  Circulation. 1991;  84 2275-2279
    CrossrefPubMedGoogle Scholar
  • 38 Pasque M K, Trulock E P, Cooper J D et al.. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients.  Circulation. 1995;  92 2252-2258
    CrossrefPubMedGoogle Scholar
  • 39 Starnes V A, Stinson E B, Oyer P E et al.. Single lung transplantation: a new therapeutic option for patients with pulmonary hypertension.  Transplant Proc. 1991;  23(1 Pt 2) 1209-1210
    PubMedGoogle Scholar
  • 40 Ueno T, Smith J A, Snell G I et al.. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome.  Ann Thorac Surg. 2000;  69 381-387
    CrossrefPubMedGoogle Scholar
  • 41 Birsan T, Zuckermann Z, Artermiou O et al.. Bilateral lung transplantation for pulmonary hypertension.  Transplant Proc. 1997;  29 2892-2894
    CrossrefPubMedGoogle Scholar
  • 42 Whyte R I, Robbins R C, Altinger J et al.. Heart–lung transplantation for primary pulmonary hypertension.  Ann Thorac Surg. 1999;  67 937-941 discussion 941-942
    CrossrefPubMedGoogle Scholar
  • 43 Mikhail G, al-Kattan K, Banner N et al.. Long-term results of heart–lung transplantation for pulmonary hypertension.  Transplant Proc. 1997;  29 633
    CrossrefPubMedGoogle Scholar
  • 44 Stoica S C, McNeil K D, Perreas K et al.. Heart–lung transplantation for Eisenmenger syndrome: early and long-term results.  Ann Thorac Surg. 2001;  72 1887-1891
    CrossrefPubMedGoogle Scholar
  • 45 Boujoukos A J, Martich G D, Vega J D, Keenan R J, Griffith B P. Reperfusion injury in single lung transplant recipients with pulmonary hypertension and emphysema.  J Heart Lung Transplant. 1997;  16 439-448
    PubMedGoogle Scholar
  • 46 Kramer M R, Marshall S E, McDougall I R et al.. The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension.  Transplant Proc. 1991;  23(1 Pt 2) 1215-1216
    PubMedGoogle Scholar
  • 47 Levine S M, Jenkinson S G, Bryan C L et al.. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension.  Chest. 1992;  101 401-405
    CrossrefPubMedGoogle Scholar
  • 48 Huerd S S, Hodges T N, Grover F L et al.. Secondary pulmonary hypertension does not adversely affect outcome after single lung transplantation.  J Thorac Cardiovasc Surg. 2000;  119 458-465
    CrossrefPubMedGoogle Scholar
  • 49 Kramer M R, Valantine H A, Marshall S E, Starnes V A, Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension.  Am J Cardiol. 1994;  73 494-500
    CrossrefPubMedGoogle Scholar
  • 50 Schulman L L, Leibowitz D W, Anandarangam T et al.. Variability of right ventricular functional recovery after lung transplantation.  Transplantation. 1996;  62 622-625
    CrossrefPubMedGoogle Scholar
  • 51 Lupinetti F M, Bolling S F, Bove E L et al.. Selective lung or heart–lung transplantation for pulmonary hypertension associated with congenital cardiac anomalies.  Ann Thorac Surg. 1994;  57 1545-1548, 1549
    CrossrefPubMedGoogle Scholar
  • 52 Waddell T K, Bennett L W, Kennedy R et al.. Lung or heart lung transplantation for Eisenmenger's syndrome: analysis of the ISHLT/UNOS joint thoracic registry [abstract].  J Heart Lung Transplant. 2000;  19 57
    PubMedGoogle Scholar
  • 53 Chapelier A, Vouhé P, Macchiarini P et al.. Comparative outcome of heart–lung and lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1993;  106 299-307
    PubMedGoogle Scholar
  • 54 Bando K, Armitage J M, Paradis I L et al.. Indications for and results of single, bilateral, and heart–lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1994;  108 1056-1065
    PubMedGoogle Scholar
  • 55 Gammie J S, Keenan R J, Pham S M et al.. Single- versus double-lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1998;  115 397-402 discussion 402-403
    CrossrefPubMedGoogle Scholar
  • 56 Conte J V, Borja M J, Patel C B, Yang S C, Jhaveri R M, Orens J B. Lung transplantation for primary and secondary pulmonary hypertension.  Ann Thorac Surg. 2001;  72 1673-1679 discussion 1679-1680
    CrossrefPubMedGoogle Scholar
  • 57 D'Alonzo G E, Barst R J, Ayres S M et al.. Survival in patients with primary pulmonary hypertension: results from a national prospective registry.  Ann Intern Med. 1991;  115 343-349
    PubMedGoogle Scholar
  • 58 Barst R J, Rubin L J, Long W A The Primary Pulmonary Hypertension Study Group et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.  N Engl J Med. 1996;  334 296-302
    CrossrefPubMedGoogle Scholar
  • 59 Robbins I M, Christman B W, Newman J H, Matlock R, Loyd J E. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension.  Chest. 1998;  114 1269-1275
    CrossrefPubMedGoogle Scholar
  • 60 Conte J V, Gaine S P, Orens J B, Harris T, Rubin L J. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.  J Heart Lung Transplant. 1998;  17 679-685
    PubMedGoogle Scholar
  • 61 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report.  J Heart Lung Transplant. 2000;  19 909-931
    CrossrefPubMedGoogle Scholar
  • 62 Pielsticker E J, Martinez F J, Rubenfire M. Lung and heart–lung transplant practice patterns in pulmonary hypertension centers.  J Heart Lung Transplant. 2001;  20 1297-1304
    CrossrefPubMedGoogle Scholar
  • 63 Rich S, Levy P S. Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension.  Am J Med. 1984;  76 573-578
    CrossrefPubMedGoogle Scholar
  • 64 Glanville A R, Burke C M, Theodore J, Robin E D. Primary pulmonary hypertension. Length of survival in patients referred for heart–lung transplantation.  Chest. 1987;  91 675-681
    CrossrefPubMedGoogle Scholar
  • 65 Eysmann S B, Palevsky H I, Reichek N, Hackney K, Douglas P S. Two dimensional echocardiography and cardiac catheterisation correlates of survival in primary pulmonary hypertension.  Circulation. 1989;  80 353-360
    CrossrefPubMedGoogle Scholar

Paul A CorrisM.B. 

Institute of Cellular Medicine

Newcastle University and Freeman Hospital, UK, NE7 7DN

Email: paul.corris@ncl.ac.uk

      >